| RS1675625092 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1675665426 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1675671187 |
CDC73
|
Health Risk |
Pathogenic |
— |
| RS1675682743 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1675685953 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1675708936 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1675709881 |
ALMS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1675711858 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1675739925 |
ALMS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1675812434 |
PREPL
|
Health Risk |
Pathogenic |
Myasthenic syndrome, congenital |
| RS1675833748 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoinflammatory syndrome, Chédiak-Higashi syndrome |
| RS1675912024 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS1675915231 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Hereditary cancer-predisposing syndrome |
| RS1675993398 |
FOXI3
|
Health Risk |
Likely pathogenic |
Craniofacial microsomia 2, Craniofacial microsomia 1 |
| RS1676028774 |
CAD
|
Health Risk |
Pathogenic |
— |
| RS1676033729 |
CAD
|
Health Risk |
Likely pathogenic |
— |
| RS1676113645 |
CAD
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 50 |
| RS1676117112 |
CAD
|
Health Risk |
Likely pathogenic |
— |
| RS1676130958 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Parathyroid carcinoma, Hereditary cancer-predisposing syndrome |
| RS1676202186 |
BCL11A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1676223605 |
LOC112806037;MERTK
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1676249686 |
CAD
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 50 |
| RS1676269150 |
BCL11A
|
Health Risk |
Likely pathogenic |
— |
| RS1676277997 |
BCL11A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental disorder, Inborn genetic diseases |
| RS1676285984 |
CAD
|
Health Risk |
Pathogenic |
— |
| RS1676294288 |
CAD
|
Health Risk |
Pathogenic |
— |
| RS1676302520 |
BCL11A
|
Health Risk |
Likely pathogenic |
Dias-Logan syndrome, Dias-Logan syndrome |
| RS1676310949 |
REEP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 31, Hereditary spastic paraplegia 31 |
| RS1676315050 |
BCL11A
|
Health Risk |
Pathogenic |
— |
| RS1676326365 |
BCL11A
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1676346981 |
BCL11A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1676385056 |
SPAST
|
Health Risk |
Pathogenic |
— |
| RS1676388641 |
SPAST
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1676391139 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1676403099 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1676404879 |
SPAST
|
Health Risk |
Pathogenic |
— |
| RS1676417081 |
SPAST
|
Health Risk |
Likely pathogenic |
— |
| RS1676453652 |
REEP1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 31, Hereditary spastic paraplegia 31 |
| RS1676463508 |
REEP1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 31, Hereditary spastic paraplegia 31 |
| RS1676557876 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1676571415 |
POU3F3
|
Health Risk |
Likely pathogenic |
Snijders blok-fisher syndrome, Snijders blok-fisher syndrome |
| RS1676571583 |
POU3F3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1676574002 |
POU3F3
|
Health Risk |
Likely pathogenic |
Snijders blok-fisher syndrome, Snijders blok-fisher syndrome |
| RS1676574259 |
POU3F3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1676689811 |
MERTK
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Retinitis pigmentosa 38 |
| RS1676833644 |
RPGRIP1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1676862579 |
MERTK
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 38, Retinitis pigmentosa 38 |
| RS1676864249 |
MERTK
|
Health Risk |
Likely pathogenic |
— |
| RS1676864299 |
MERTK
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1676864420 |
MERTK
|
Health Risk |
Likely pathogenic |
— |
| RS1676864515 |
MERTK
|
Health Risk |
Likely pathogenic |
— |
| RS1676898074 |
NBAS
|
Health Risk |
Likely pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS1676904823 |
MERTK
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal disorder |
| RS1676926630 |
MERTK
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 38, Retinitis pigmentosa 38 |
| RS1677003855 |
REEP1
|
Health Risk |
Pathogenic |
— |
| RS1677010564 |
REEP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 31, Hereditary spastic paraplegia 31 |
| RS1677011138 |
REEP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 31, Hereditary spastic paraplegia 31 |
| RS1677065097 |
MERTK
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Autosomal recessive retinitis pigmentosa |
| RS1677131770 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Parathyroid carcinoma, Hyperparathyroidism 1 |
| RS1677132309 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS1677161997 |
CYP26B1
|
Health Risk |
Likely pathogenic |
Lethal occipital encephalocele-skeletal dysplasia syndrome, Lethal occipital encephalocele-skeletal dysplasia syndrome |
| RS1677289241 |
MERTK
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1677321281 |
SLC5A7
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 20, Neuronopathy |
| RS1677347565 |
MERTK
|
Health Risk |
Pathogenic |
— |
| RS1677368092 |
MERTK
|
Health Risk |
Pathogenic |
— |
| RS1677397982 |
NAXE
|
Health Risk |
Pathogenic |
Encephalopathy, progressive |
| RS1677398842 |
NAXE
|
Health Risk |
Pathogenic |
Encephalopathy, progressive |
| RS1677410327 |
SFTPB
|
Health Risk |
Pathogenic |
Hereditary pulmonary alveolar proteinosis, Hereditary pulmonary alveolar proteinosis |
| RS1677411235 |
SFTPB
|
Health Risk |
Pathogenic |
— |
| RS1677478183 |
SLC5A7
|
Health Risk |
Likely pathogenic |
Neuronopathy, distal hereditary motor |
| RS1677512620 |
MERTK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1677514061 |
MERTK
|
Health Risk |
Pathogenic |
— |
| RS1677532605 |
SPAST
|
Health Risk |
Pathogenic |
— |
| RS1677532829 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1677533134 |
SPAST
|
Health Risk |
Pathogenic |
— |
| RS1677533628 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1677547983 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile liver failure syndrome 2, Short stature-optic atrophy-Pelger-Huët anomaly syndrome |
| RS1677552802 |
NBAS
|
Health Risk |
Likely pathogenic |
— |
| RS1677627735 |
SPAST
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1677627829 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1677628649 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1677658252 |
SFTPB
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS1677688362 |
CDC73
|
Health Risk |
Pathogenic/Likely pathogenic |
Parathyroid carcinoma, Hyperparathyroidism 2 with jaw tumors |
| RS1677695565 |
ZAP70
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to ZAP70 deficiency, Combined immunodeficiency due to ZAP70 deficiency |
| RS1677697539 |
M1AP
|
Health Risk |
Pathogenic |
Spermatogenesis maturation arrest, Spermatogenic failure 48 |
| RS1677757408 |
CDC73
|
Health Risk |
Pathogenic |
— |
| RS1677757559 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS1677776275 |
PTPN4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1677953034 |
ZAP70
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to ZAP70 deficiency, Combined immunodeficiency due to ZAP70 deficiency |
| RS1678013520 |
LPIN1
|
Health Risk |
Likely pathogenic |
Myoglobinuria, acute recurrent |
| RS1678015232 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Parathyroid carcinoma, Hereditary cancer-predisposing syndrome |
| RS1678016165 |
CDC73
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1678079858 |
ASPRV1
|
Health Risk |
Pathogenic |
Autosomal dominant lamellar ichthyosis, Autosomal dominant lamellar ichthyosis |
| RS1678115852 |
SLC5A7
|
Health Risk |
Likely pathogenic |
Neuronopathy, distal hereditary motor |
| RS1678240011 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 2, Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome |
| RS1678261343 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiomyopathy |
| RS1678270963 |
SLC5A7
|
Health Risk |
Likely pathogenic |
— |
| RS1678284190 |
EN1
|
Health Risk |
Pathogenic |
EN1 syndrome, ENDOVE syndrome |
| RS1678323186 |
LPIN1
|
Health Risk |
Pathogenic |
— |
| RS1678508737 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |